The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke
Open accessAbstract
Background and Purpose —To test the safety and recanalization efficacy of intra-arterial local delivery of plasminogen activators in acute ischemic stroke, a randomized trial of recombinant pro-urokinase (rpro-UK) versus placebo was undertaken in patients with angiographically documented proximal middle cerebral artery occlusion. Methods —After exclusion of intracranial hemorrhage by CT scan, patients with abrupt onset of symptoms of focal ischemia likely to receive treatment within 6 hours who satisfied all clinical eligibility criteria underwent carotid angiography. Patients displaying Thrombolysis in Acute Myocardial Infarction grade 0 or 1 occlusion of the M1 or M2 middle cerebral artery were randomized 2:1 to receive rpro-UK (6 mg) or placebo over 120 minutes into the proximal thrombus face. All patients received intravenous heparin. Recanalization efficacy was assessed at the end of the 2-hour infusion, and intracerebral hemorrhage causing neurological deterioration was assessed at 24 hours. Results —Of 105 patients who underwent angiography, 59 were excluded from randomization. Among the 46 patients randomized, 40 were treated with rpro-UK (n=26) or placebo (n=14) a median of 5.5 hours from symptom onset. Recanalization was significantly associated with rpro-UK (2 P =.017). Hemorrhagic transformation causing neurological deterioration within 24 hours of treatment occurred in 15.4% of the rpro-UK–treated patients and 7.1% of the placebo-treated patients (2 P =.64). Both recanalization and hemorrhage frequencies were influenced by heparin dose. Conclusions —Intra-arterial local rpro-UK infusion was associated with superior recanalization in acute thrombotic/thromboembolic stroke compared with placebo. In this regimen, heparin dose influenced hemorrhage frequency and recanalization. Although symptomatic hemorrhage remains a concern, this study suggests that recanalization is enhanced with rpro-UK and heparin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Self-citationInterrater Reliability of the NIH Stroke Scale
Goldstein, L. B., Bertels, C., & Davis, J. N. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420080026 · Cited by 986
Hacke, W., Zeumer, H., Ferbert, A., Brückmann, H., & del Zoppo, G. J. (1988) · Stroke · doi:10.1161/01.str.19.10.1216 · Cited by 825
Self-citationMulticentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A., & Yamadori, A. (1992) · Neurology · doi:10.1212/wnl.42.5.976 · Cited by 472
Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours
Fieschi, C., Argentino, C., Lenzi, G. L., Sacchetti, M. L., Toni, D., & Bozzao, L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90060-9 · Cited by 407
Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.
del Zoppo, G. J., Ferbert, A., Otis, S. M., Brückmann, H., Hacke, W., Zyroff, J., Harker, L. A., & Zeumer, H. (1988) · Stroke · doi:10.1161/01.str.19.3.307 · Cited by 382
Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.
Mori, E., Tabuchi, M., Yoshida, T., & Yamadori, A. (1988) · Stroke · doi:10.1161/01.str.19.7.802 · Cited by 362
Hantson, L., De Weerdt, W., De Keyser, J., Diener, H. C., Franke, C., Palm, R., Van Orshoven, M., Schoonderwalt, H., De Klippel, N., & Herroelen, L. (1994) · Stroke · doi:10.1161/01.str.25.11.2215 · Cited by 199
Trials of streptokinase in severe acute ischaemic stroke
Shahar, E., McGovern, P., Hommel, M., Pierre Boissel, J., Donnan, G., Davis, S., Chambers, B., Gates, P., Hankey, G., McNeil, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90484-0 · Cited by 188
Fleury, V., & Angles-Cano, E. (1991) · Biochemistry · doi:10.1021/bi00244a035 · Cited by 187
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke
Yamaguchi, T., Hayakawa, T., & Kiuchi, H. (1993) · Cerebrovascular Diseases · doi:10.1159/000108714 · Cited by 152
Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease
Stefanadis, C., & TOUTOUZAS, P. K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91066-2 · Cited by 142
Pannell, R., & Gurewich, V. (1987) · Blood · doi:10.1182/blood.v69.1.22.22 · Cited by 134
Thrombolytic Intervention in Acute Thrombotic and Embolic Stroke
del Zoppo, G., Pessin, M. S., Mori, E., & Hacke, W. (1991) · Seminars in Neurology · doi:10.1055/s-2008-1041241 · Cited by 80
Self-citationHemorrhagic Transformation in the Natural History of Acute Embolic Stroke
Pessin, M. S. (1991) · Springer eBooks · doi:10.1007/978-3-642-76439-4_7 · Cited by 15
Self-citation
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Berkhemer, O. A., Fransen, P. S. S., Beumer, D., van den Berg, L. A., Lingsma, H. F., Yoo, A. J., Schonewille, W. J., Vos, J. A., Nederkoorn, P. J., Wermer, M. J. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411587 · Cited by 6,657
Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,073
Self-citationAdams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Self-citationHigashida, R. T., & Furlan, A. J. (2003) · Stroke · doi:10.1161/01.str.0000082721.62796.09 · Cited by 1,543
Self-citation
Metadata
- Authors
- del Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., & Gent, M.
- Venue
- Stroke
- Published
- 1998-01
- Volume
- 29
- Issue
- 1
- Pages
- 4-11
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2146307187
- Cited by
- 1,239
- References
- 21
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.